AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$IRMD

IRADIMED CORP

Price · $IRMDvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $IRMD in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $IRMD in the last 30 days.

Top stories · $IRMDMore →
APR 26·HarianBasis.coHigh

Iradimed Corp Stock Receives Strong Buy Ratings from Analysts

Iradimed Corp (NASDAQ: IRMD) has received "Buy" ratings from all three analysts covering the stock, with a median one-year target price suggesting a nearly 34% upside. This positive outlook is driven by the company's unique position as the sole provider of non-magnetic MRI-compatible IV infusion pumps and patient monitoring systems, along with its product growth and potential for international expansion. Freedom Broker initiated coverage with a Buy rating and a $116 price target, highlighting Iradimed's profitability and specialized product portfolio.

DEC 23·Investing.com Canada

Iradimed stock reaches all-time high at 98.24 USD By Investing.com

Iradimed Co (IRMD) stock has reached an all-time high of $98.24, close to its 52-week high of $98.44, reflecting robust growth over the past year. The company has a market capitalization of $1.25 billion and an 80.67% increase over the past year, with a 68.49% gain in the last six months. InvestingPro's analysis suggests the stock might be overvalued with a P/E ratio of 58.94.

DEC 9·MarketBeat

iRadimed Corporation (NASDAQ:IRMD) Plans $0.50 Special Dividend

iRadimed Corporation (NASDAQ:IRMD) announced a special dividend of $0.50 per share, payable on December 30th to shareholders of record on December 17th, with the ex-dividend date also on December 17th. The dividend is covered by earnings, with a payout ratio around 34% and expected EPS of $2.00 next year. Shares recently traded at $95.48 after beating Q last EPS estimates, and Wall Street maintains a "Moderate Buy" rating with an average price target of $87.33.

News on $IRMD

All news →